Core Insights - The announcement of the completion of the ETHK building marks a significant milestone for the company as it transitions to a new strategic focus on blockchain technology and compliance in the financial ecosystem [4][5][8] - The new logo symbolizes the company's evolution into a builder of next-generation on-chain financial ecosystems, moving beyond its previous identity [4][8] Group 1: ETHK Building and Its Significance - The ETHK building is the world's first core base dedicated to the research and ecological empowerment of Real World Assets (RWA) digitalization technology, located in Nanjing with a total area of approximately 70,000 square meters [5][7] - The building serves a dual purpose: as a physical infrastructure for research and collaboration, and as a credible technology development and output center, expected to gather over 5,000 technical experts and engineers [7][8] - Nanjing was chosen for its strategic alignment with the company's focus on high-tech intellectual property asset digitalization and its proximity to top universities, providing talent support [7][8] Group 2: RWA Ecosystem and Strategic Transformation - The logo update and building completion represent the company's "second entrepreneurship," fully transitioning to the RWA sector, which involves the tokenization of real-world assets [8][9] - The RWA market is projected to grow significantly, with a total locked value expected to reach $12.5 billion by June 2025, a 124% increase from 2024 [8][9] - The company has established ETHK Inc. and ETHK HOLDINGS LIMITED to position itself as a technology driver and infrastructure provider in the RWA ecosystem [8][9] Group 3: Strategic Partnerships and Business Model Innovation - The company announced a strategic partnership with Renhe Pharmaceutical to establish the world's first OTC vertical RWA exchange in the U.S., marking a key case for its "exchange within an exchange" business model [9][10] - This innovative model aims to provide on-chain financial infrastructure for leading enterprises across various industries, facilitating the creation of vertical RWA exchanges [10] - The partnership is expected to enhance both parties' capabilities, enabling the internationalization of Chinese assets and the introduction of innovative OTC products from abroad [10][11] Group 4: Value Creation and Market Potential - The company's RWA strategy aims to create multidimensional value, emphasizing altruistic values and contributing to national strategies and public welfare [11][12] - The collaboration with Renhe Pharmaceutical is set to revolutionize the OTC industry by enhancing innovation efficiency across the entire value chain [11][12] - The RWA market is on the verge of significant growth, with major financial institutions entering the space, positioning the company to lead in this emerging sector [12][13]

Core Viewpoint - The company Huajian Medical (01931) is undergoing a strategic transformation by establishing two new companies in collaboration with ETHK Group, focusing on the tokenization of equity assets and the development of a global blockchain financial ecosystem [1][6]. Group 1: Company Developments - Huajian Medical announced the formation of ETHK Inc. and ETHK HOLDINGS LIMITED to enhance its global blockchain financial strategy, particularly in promoting "on-chain stocks" [1]. - The company plans to change its English name to "ETHK Labs Inc." and its Chinese name to "华检数字产业集团有限公司" to reflect its ambition to become a leader in digital industry innovation and blockchain technology [1]. - Following the announcement, Huajian Medical's stock price surged approximately 8%, closing at HKD 10.71, a significant increase from HKD 2.22 on July 2 [1]. Group 2: Industry Trends - Asset tokenization is emerging as a significant trend in global financial markets, with Galaxy Digital recently allowing shareholders to tokenize and hold GLXY stocks on-chain, marking a notable case of stock tokenization by a public company [4]. - The advantages of on-chain stocks include 24/7 trading, near-instant settlement, reduced transaction costs, and seamless global circulation, driving a revolution in traditional financial assets [4]. - A joint prediction by Boston Consulting Group and ADDX estimates that by 2030, the global Real World Asset (RWA) market will reach USD 16.1 trillion, accounting for 10% of global GDP [4]. Group 3: Strategic Vision - The strategic upgrade of Huajian Medical aims to systematically build the "ETHK" blockchain financial ecosystem, which includes five core pillars: technical infrastructure, financial product matrix, sustainable models, global compliance framework, and seamless user access [6][9]. - The establishment of the two joint ventures allows Huajian Medical to focus on technology platform development while integrating global quality resources through capital means, creating a self-sustaining growth model [9]. - The company's vision aligns with national policies promoting financial technology innovation and digital economic development, potentially providing new channels for global financing and circulation of high-quality Chinese assets [10].

Core Viewpoint - The announcement by Huajian Medical (01931.HK) regarding the establishment of joint ventures and a rebranding signifies a strategic shift towards "on-chain finance," aiming to build the next generation of global asset circulation infrastructure [1][3]. Group 1: Strategic Shift - The name change from "IVD Medical Holding Limited" to "ETHK Labs Inc." reflects a new strategic vision that aligns with its role as a key technology and infrastructure provider in the "ETHK on-chain financial ecosystem" [1][3]. - The establishment of joint ventures alongside the rebranding indicates a systematic increase in investment in digital industries and on-chain finance, suggesting a long-term commitment rather than short-term market speculation [3]. Group 2: Trust Mechanism - There are two contrasting perspectives on Huajian Medical's transformation: supporters believe blockchain can effectively address global asset liquidity issues, while skeptics question the scalability of RWA (Real World Asset) and the clarity of the business model [4][6]. - The ability to build a sustainable, regulatory-compliant, and scalable trust system is crucial for the success of Huajian Medical's strategy [6]. Group 3: Strategic Drivers - The transformation is driven by three factors: the need to overcome growth bottlenecks in existing business, the necessity to attract investor attention with a new global and tech-oriented narrative, and the supportive policy environment in Hong Kong for Web3 and digital asset innovation [8]. Group 4: Value Distribution - Huajian Medical's ETHK ecosystem aims to create new opportunities for asset owners by providing pathways for financing and global market access through on-chain tools [9]. - For capital providers, Huajian Medical is expected to offer new investment interfaces that connect them to high-quality assets traditionally overlooked by the financial system [9]. Group 5: Conclusion - The establishment of joint ventures and the rebranding highlight a significant trend where Chinese quality assets are attempting to achieve global circulation through blockchain technology, while global capital seeks new value anchors [11]. - The success of Huajian Medical in converting its narrative of "on-chain finance" into a credible, investable, and sustainable reality will depend on its ability to address technical implementation, compliance, business models, and ecosystem collaboration [11][12].

Core Viewpoint - The announcement by Huajian Medical on September 14 signifies a strategic shift towards integrating the pharmaceutical industry with blockchain finance, indicating a new attempt for Chinese quality assets to go global [1][5]. Group 1: Company Strategy - Huajian Medical is transitioning to focus on digital industries and blockchain finance to create new growth avenues and enhance long-term shareholder value [6]. - The rebranding to "ETHK Labs Inc." reflects the company's new positioning as a key technology and infrastructure provider within the ETHK blockchain financial ecosystem [6][11]. - The establishment of ETHK INC and ETHK HOLDINGS LIMITED aims to develop a decentralized financial platform and serve as an investment and acquisition hub for digital industries [7][11]. Group 2: Global Asset Tokenization - Huajian Medical's strategy includes exploring the tokenization of global assets, particularly focusing on the tokenization of equity assets, which allows for efficient and compliant global financing and value discovery [9]. - The initiative aims to convert research outcomes and intellectual property into tradable digital assets, broadening financing channels for companies [9]. Group 3: Compliance and Security - The joint venture emphasizes compliance and security, seeking relevant financial and payment licenses globally, and establishing a comprehensive compliance framework [10]. - The framework includes KYC, AML, and CFT procedures, along with risk management tools to ensure the secure circulation of innovative assets on the blockchain [10]. Group 4: Strategic Significance - The collaboration with ETHK Group represents a significant upgrade in Huajian Medical's strategy, aligning with the global trend of financial asset digitization and blockchain integration [11]. - This strategic layout provides a broader platform for quality assets and diverse investment opportunities while ensuring safety through a strict compliance framework [11]. Group 5: Future Considerations - The development of the blockchain financial ecosystem is still in its early stages, facing challenges in technology, regulation, and market perception [13]. - Key questions include how to overcome technical barriers, establish a unified regulatory framework, and enhance market participants' understanding of blockchain finance [13].

Core Viewpoint - The announcement by Huajian Medical Holdings Limited regarding its partnership with ETHK Group marks a significant step towards creating a new financial ecosystem on the blockchain, aiming to facilitate the global flow and reconstruction of value, particularly in the Chinese healthcare sector [1][3]. Group 1: Company Overview - Huajian Medical is transitioning from a focus on in vitro diagnostics (IVD) to a broader role in the financial ecosystem by exploring the integration of assets and finance [7]. - The company is rebranding itself to reflect its new strategic direction, changing its name to Huajian Digital Industry Group Limited [1]. Group 2: Strategic Initiatives - The establishment of ETHK INC and ETHK HOLDINGS LIMITED is not merely a capital partnership but aims to build a decentralized and open financial platform [4]. - The ETHK ecosystem is built on five key pillars: technological infrastructure, financial products and asset matrix, sustainable business models, global compliance frameworks, and seamless user experience [5][6]. Group 3: Market Positioning - The collaboration is seen as a strategic extension that addresses the challenges of capital acceptance and value realization for innovative assets [7]. - The tokenization of assets is expected to enhance liquidity and provide a global platform for investment, breaking down geographical and institutional barriers [8][9]. Group 4: Industry Implications - The initiative is positioned as part of a broader trend towards the tokenization of real-world assets (RWA), which is gaining traction among major financial institutions [11]. - The ETHK ecosystem aims to serve as a public infrastructure for the global economy, emphasizing the importance of technology in rebuilding trust and facilitating cooperation [11]. Group 5: Future Outlook - The partnership represents a bold attempt to redefine the narrative of Chinese assets in the global capital landscape, with the potential to reshape financial order [14][15]. - The success of this venture could lead to significant changes in how value is discovered and exchanged on a global scale, particularly for Chinese innovative assets [13][15].

Core Viewpoint - The announcement by Huajian Medical Holdings Limited regarding its partnership with ETHK Group marks a significant step towards creating a new financial ecosystem on the blockchain, aiming to facilitate the global flow and reconstruction of value, particularly in the Chinese healthcare sector [1][4]. Group 1: Company Strategy and Structure - Huajian Medical has rebranded itself to Huajian Digital Industry Group Limited and established two new companies, ETHK INC and ETHK HOLDINGS LIMITED, to focus on building a decentralized and compliant financial platform [1][4]. - The ETHK ecosystem is built on five key pillars: technological infrastructure, financial products and asset matrix, sustainable business models, global compliance and trust framework, and seamless user experience [6][7]. Group 2: Financial Innovation and Market Position - The collaboration aims to tokenize real-world assets (RWA) and enhance liquidity, allowing assets to be traded like stocks and bonds, thus breaking geographical and institutional barriers [8][9]. - Huajian Medical is positioning itself not just as a participant in the healthcare sector but as a key organizer in the global capital chain, leveraging blockchain technology to address traditional financial system limitations [10][12]. Group 3: Global Financial Landscape - The initiative is seen as part of a broader trend towards the digitization of finance, with RWA tokenization becoming a significant focus for major financial institutions globally [11][12]. - The partnership is expected to create a new narrative for Chinese assets in the global capital landscape, facilitating a more balanced capital market and enabling global value discovery [13][15].

Core Viewpoint - The announcement by Huajian Medical Holdings Limited regarding its partnership with ETHK Group marks a significant step towards creating a new financial ecosystem on the blockchain, aiming to enhance the global flow and reconstruction of value in the healthcare sector [1][5]. Group 1: Company Strategy and Transformation - Huajian Medical has changed its name to Huajian Digital Industry Group Limited, reflecting its strategic shift towards digital finance and blockchain technology [1][4]. - The collaboration with ETHK Group aims to establish two new companies, ETHK INC and ETHK HOLDINGS LIMITED, focusing on decentralized financial platforms and global capital integration [1][6]. - The partnership is seen as a strategic extension of Huajian Medical's efforts to explore a dual-driven model of "assets + finance," enhancing the liquidity and global accessibility of its innovative assets [9][11]. Group 2: ETHK Ecosystem Development - The ETHK ecosystem is built on five key pillars: technological infrastructure, financial products and asset matrix, sustainable business models, global compliance frameworks, and seamless user experience [7][8]. - The focus on asset tokenization, particularly in the healthcare sector, aims to facilitate efficient global financing and value discovery for high-quality Chinese assets [8][12]. - The initiative is positioned as a response to the growing trend of Real World Asset (RWA) tokenization, which is gaining traction among major financial institutions globally [12][14]. Group 3: Market Implications and Future Outlook - The collaboration is expected to redefine the global financial landscape by breaking down barriers for Chinese assets and enabling them to engage in a global value dialogue [13][14]. - The project is viewed as a significant opportunity for Chinese enterprises to align with global regulatory frameworks while innovating within the blockchain space [15]. - The success of this initiative could position Huajian Medical as a key player in the emerging digital financial ecosystem, potentially reshaping the global financial order [16][17].

Core Viewpoint - Huajian Medical (01931) is undergoing a strategic transformation to become a digital industry technology innovator, marking a shift from a traditional medical enterprise to a focus on blockchain and decentralized finance through the establishment of new companies and a name change [1][3][4]. Group 1: Strategic Transformation - Huajian Medical has announced a partnership with ETHK Group to jointly invest in two new companies, ETHK Inc and ETHK HOLDINGS LIMITED, aimed at developing a decentralized financial platform and a digital industry investment hub [4][6]. - The company will change its name from "IVD Medical Holding Limited" to "ETHK Labs Inc." and its Chinese name to "Huajian Digital Industry Group Limited," reflecting its ambition to become a core technology driver in the global digital industry [3][6]. Group 2: ETHK Ecosystem - The "ETHK" brand name combines "ETH" (Ether) and "K" (Kingdom), symbolizing a vision for a decentralized financial ecosystem that aligns with blockchain technology [7]. - ETHK Labs will focus on advanced technology research and development, serving as the technological foundation and innovation engine for the ETHK ecosystem [7]. Group 3: RWA Market Opportunity - The transformation aligns with the explosive growth of the Real World Asset (RWA) market, which saw a total locked value (TVL) increase from $8.6 billion to over $23 billion in the first half of 2025, a growth of over 260% [8][9]. - Predictions indicate that the global RWA market could reach $16.1 trillion by 2030, representing 10% of global GDP, positioning Huajian Medical to lead in RWA infrastructure development [9]. Group 4: Value Reconstruction - The strategic upgrade aims to enhance China's global digital financial influence by facilitating the "on-chain" transition of quality Chinese assets [10]. - The ETHK ecosystem is expected to address financing challenges for enterprises and promote global asset integration, contributing to financial inclusivity and stability [10]. - The company's valuation model is shifting from traditional earnings-based metrics to revenue-based metrics, reflecting its new focus on digital infrastructure [10].

Core Viewpoint - Huajian Medical (01931) has announced a strategic upgrade, including the establishment of two joint ventures with ETHK Group and a name change to reflect its transformation into a digital industry innovator [1][4][5]. Group 1: Strategic Transformation - The company has formed joint ventures, ETHK Inc and ETHK HOLDINGS LIMITED, to enhance its global blockchain financial ecosystem [5]. - ETHK Inc will focus on developing a decentralized financial platform under the "ETHK" brand, while ETHK HOLDINGS LIMITED will serve as a digital industry investment and acquisition hub [5]. - The company will change its name from "IVD Medical Holding Limited" to "ETHK Labs Inc." and its Chinese name to "华检数字产业集团有限公司" [4][5]. Group 2: Blockchain Financial Ecosystem - The "ETHK" brand name combines "Ether" and "Kingdom," symbolizing a decentralized financial ecosystem that aligns with blockchain technology [9]. - ETHK Labs will be the core institution for advanced technology research and ecosystem empowerment within the ETHK framework [9]. - The company aims to redefine global asset circulation and value exchange through a next-generation blockchain financial ecosystem [9]. Group 3: RWA Market Opportunity - The transformation aligns with the explosive growth of the Real World Asset (RWA) market, which saw a total locked value (TVL) of $12.5 billion as of June 2025, a 124% increase from 2024 [10]. - The RWA market surged from $8.6 billion to over $23 billion in the first half of 2025, marking a growth of over 260% [11]. - By establishing joint ventures and rebranding, the company positions itself to lead the global RWA infrastructure development [11]. Group 4: Value Reconstruction - The strategic upgrade aims to enhance China's global digital financial influence by facilitating the "on-chain" movement of quality Chinese assets [12]. - The blockchain financial model promotes transparency and efficiency, addressing financing challenges for enterprises and supporting global asset integration [13]. - The transformation signifies a shift in valuation logic from traditional earnings-based models to revenue-based models, reflecting the company's new focus on digital infrastructure [13].

公告称，为更准确地体现集团作为"ETHK"链上金融生态体系关键技术与基础设施提供者的全新定位， 董事会认为，更改公司名称符合公司及股东的整体最佳利益。新名称"ETHK Labs Inc./华检数字产业集 团有限公司"将更能代表集团致力于成为全球数字产业创新与链上金融核心技术驱动者的宏伟抱负。 智通财经APP讯，华检医疗(01931)公布，董事会建议将公司的英文名称由"IVD Medical Holding Limited"更改为"ETHK Labs Inc."，并将公司的中文双重外文名称由"华检医疗控股有限公司"更改为"华 检数字产业集团有限公司"。 ...